Trovagene, Inc. Announces First Quarter 2014 Financial Results

[PR Newswire] – SAN DIEGO, May 12, 2014 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the three months ended March 31, 2014. Our … more

View todays social media effects on TROV

View the latest stocks trending across Twitter. Click to view dashboard

See who TrovaGene is hiring next, click here to view